8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Mar 23, 2026·SEC
Material company update
Mar 5, 2026·SEC
Cardinal Health, Inc.(CAH)Earnings, Financials & Key Ratios
CAH•NYSE
$197.00
$46.36B mkt cap·30.5× P/E·Price updated May 6, 2026
AboutCardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.Show more
- Revenue$222.58B-1.9%
- EBITDA$3.06B+56.9%
- Net Income$1.56B+83.2%
- EPS (Diluted)6.45+87.0%
- Gross Margin3.67%+12.3%
- EBITDA Margin1.38%+59.9%
- Operating Margin1.02%+86.5%
- Net Margin0.7%+86.7%
- ROIC3378.71%
- Interest Coverage10.77-56.1%
CAH Key Insights
Cardinal Health, Inc. (CAH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓20 consecutive years of dividend growth
- ✓High quality earnings: Operating CF exceeds net income
- ✓Share count reduced 2.0% through buybacks
- ✓Efficient asset utilization: 4.2x turnover
✗Weaknesses
- ✗Thin 5Y average net margin of 0.2%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
CAH Price & Volume
Cardinal Health, Inc. (CAH) stock price & volume — 10-year historical chart
Loading chart...
CAH Growth Metrics
Cardinal Health, Inc. (CAH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years8.06%
5 Years7.8%
3 Years7.07%
TTM12.8%
Profit CAGR
10 Years2.54%
5 Years-
3 Years-
TTM0.06%
EPS CAGR
10 Years5.95%
5 Years-
3 Years-
TTM2.03%
Return on Capital
10 Years5.7%
5 Years7.51%
3 Years12.92%
Last Year19.19%
CAH Recent Earnings
Cardinal Health, Inc. (CAH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Apr 30, 2026EPS
$3.17
Est $2.79
+13.6%
Revenue
$60.9B
Est $62.1B
-1.9%
Q1 2026
Feb 5, 2026EPS
$2.63
Est $2.34
+12.4%
Revenue
$65.6B
Est $65.1B
+0.8%
Q4 2025
Oct 30, 2025EPS
$2.55
Est $2.18
+17.0%
Revenue
$64.0B
Est $59.2B
+8.1%
Q3 2025
Aug 12, 2025EPS
$2.08
Est $2.04
+2.0%
Revenue
$60.2B
Est $60.9B
-1.2%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $3.17vs $2.79+13.6% | $60.9Bvs $62.1B-1.9% |
| Q1 2026 | Feb 5, 2026 | $2.63vs $2.34+12.4% | $65.6Bvs $65.1B+0.8% |
| Q4 2025 | Oct 30, 2025 | $2.55vs $2.18+17.0% | $64.0Bvs $59.2B+8.1% |
| Q3 2025 | Aug 12, 2025 | $2.08vs $2.04+2.0% | $60.2Bvs $60.9B-1.2% |
Based on last 12 quarters of dataView full earnings history →
CAH Peer Comparison
Cardinal Health, Inc. (CAH) competitors in Drug Wholesalers and Distributors — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 MCK | 98.11B | 801.01 | 31.14 | 16.22% | 1.09% | 5.33% | ||
 HSIC | 8.53B | 74.37 | 22.74 | 4.03% | 3.02% | 8.24% | 6.71% | 0.77 |
 OMI | 171.11M | 2.24 | -0.16 | -74.19% | -39.85% | -21.12% | ||
 NXST | 6.04B | 199.14 | 66.38 | -8.47% | 2.2% | 12.3% | ||
 JNJ | 543.64B | 225.59 | 38.96 | 4.3% | 27.26% | 31.69% | 3.65% | 0.51 |
 PFE | 150.4B | 26.44 | 19.44 | -1.65% | 11.83% | 8.34% | 6.03% | 0.78 |
 ABT | 151.59B | 87.18 | 11.41 | 4.59% | 31.88% | 27.26% | 4.19% | 0.32 |
 BDX | 52.23B | 144.17 | 24.73 | 8.23% | 8.01% | 6.93% | 5.11% | 0.76 |
Compare CAH vs Peers
Cardinal Health, Inc. (CAH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CAH Income Statement
Cardinal Health, Inc. (CAH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 129.98B | 136.81B | 145.53B | 152.92B | 162.47B | 181.33B | 204.98B | 226.83B | 222.58B | 250.55B |
| Revenue Growth % | 6.94% | 5.26% | 6.38% | 5.08% | 6.24% | 11.61% | 13.04% | 10.66% | -1.87% | 12.8% |
| Cost of Goods Sold | 123.43B | 129.63B | 138.7B | 146.05B | 155.69B | 174.84B | 198.1B | 219.41B | 214.41B | 241.32B |
| COGS % of Revenue | 94.97% | 94.75% | 95.3% | 95.51% | 95.83% | 96.42% | 96.65% | 96.73% | 96.33% | - |
| Gross Profit | 6.54B▲ 0% | 7.18B▲ 9.7% | 6.83B▼ 4.8% | 6.87B▲ 0.5% | 6.78B▼ 1.3% | 6.48B▼ 4.3% | 6.89B▲ 6.2% | 7.41B▲ 7.6% | 8.17B▲ 10.2% | 9.23B▲ 0% |
| Gross Margin % | 5.03% | 5.25% | 4.7% | 4.49% | 4.17% | 3.58% | 3.36% | 3.27% | 3.67% | 3.68% |
| Gross Profit Growth % | 0.02% | 9.73% | -4.83% | 0.5% | -1.31% | -4.34% | 6.25% | 7.62% | 10.17% | - |
| Operating Expenses | 4.42B | 7.05B | 4.77B | 10.97B | 6.31B | 7.09B | 6.12B | 6.17B | 5.89B | 6.92B |
| OpEx % of Revenue | 3.4% | 5.16% | 3.28% | 7.17% | 3.88% | 3.91% | 2.99% | 2.72% | 2.65% | - |
| Selling, General & Admin | 3.77B | 4.6B | 4.48B | 4.57B | 4.53B | 4.51B | 4.8B | 5B | 5.38B | 5.99B |
| SG&A % of Revenue | 2.9% | 3.36% | 3.08% | 2.99% | 2.79% | 2.49% | 2.34% | 2.2% | 2.42% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 649M | 2.46B | 294M | 6.39B | 1.77B | 2.58B | 1.32B | 1.17B | 511M | 3M |
| Operating Income | 2.12B▲ 0% | 126M▼ 94.1% | 2.06B▲ 1534.9% | -4.1B▼ 298.9% | 472M▲ 111.5% | -607M▼ 228.6% | 752M▲ 223.9% | 1.24B▲ 65.3% | 2.27B▲ 83.0% | 2.31B▲ 0% |
| Operating Margin % | 1.63% | 0.09% | 1.42% | -2.68% | 0.29% | -0.33% | 0.37% | 0.55% | 1.02% | 0.92% |
| Operating Income Growth % | -13.79% | -94.06% | 1534.92% | -298.93% | 111.52% | -228.6% | 223.89% | 65.29% | 83.02% | - |
| EBITDA | 2.84B | 1.16B | 3.06B | -3.19B | 1.25B | 85M | 1.44B | 1.95B | 3.06B | 3.17B |
| EBITDA Margin % | 2.18% | 0.85% | 2.1% | -2.08% | 0.77% | 0.05% | 0.7% | 0.86% | 1.38% | 1.26% |
| EBITDA Growth % | -8.48% | -59.18% | 164.25% | -204.08% | 139.4% | -93.23% | 1598.82% | 35.25% | 56.94% | 4.8% |
| D&A (Non-Cash Add-back) | 717M | 1.03B | 1B | 913M | 783M | 692M | 692M | 710M | 790M | 855M |
| EBIT | 2.13B | 101M | 2.04B | -3.53B | 503M | -637M | 747M | 1.25B | 2.32B | 2.19B |
| Net Interest Income | -201M | -329M | -294M | -238M | -180M | -147M | -84M | -51M | -215M | -343M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 201M | 329M | 294M | 238M | 180M | 147M | 84M | 51M | 215M | 343M |
| Other Income/Expense | -196M | -354M | -309M | 326M | -149M | -177M | -89M | -42M | -174M | -308M |
| Pretax Income | 1.92B▲ 0% | -228M▼ 111.9% | 1.75B▲ 868.0% | -3.77B▼ 315.4% | 323M▲ 108.6% | -784M▼ 342.7% | 663M▲ 184.6% | 1.2B▲ 81.1% | 2.1B▲ 74.9% | 2B▲ 0% |
| Pretax Margin % | 1.48% | -0.17% | 1.2% | -2.47% | 0.2% | -0.43% | 0.32% | 0.53% | 0.94% | 0.8% |
| Income Tax | 630M | -487M | 386M | -79M | -289M | 153M | 332M | 348M | 532M | 456M |
| Effective Tax Rate % | 32.74% | 213.6% | 22.04% | 2.09% | -89.47% | -19.52% | 50.08% | 28.98% | 25.32% | 22.75% |
| Net Income | 1.29B▲ 0% | 256M▼ 80.1% | 1.36B▲ 432.4% | -3.69B▼ 370.9% | 611M▲ 116.5% | -938M▼ 253.5% | 330M▲ 135.2% | 852M▲ 158.2% | 1.56B▲ 83.2% | 1.56B▲ 0% |
| Net Margin % | 0.99% | 0.19% | 0.94% | -2.42% | 0.38% | -0.52% | 0.16% | 0.38% | 0.7% | 0.62% |
| Net Income Growth % | -9.74% | -80.12% | 432.42% | -370.95% | 116.54% | -253.52% | 135.18% | 158.18% | 83.22% | 0.06% |
| Net Income (Continuing) | 1.29B | 259M | 1.36B | -3.69B | 612M | -937M | 331M | 853M | 1.57B | 1.55B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 20M | 0 | 2M | 3M | 3M | 3M | 1M | 1M | 147M | 160M |
| EPS (Diluted) | 4.03▲ 0% | 0.81▼ 79.9% | 4.53▲ 459.3% | -12.60▼ 378.1% | 2.08▲ 116.5% | -3.34▼ 260.6% | 1.26▲ 137.7% | 3.45▲ 173.8% | 6.45▲ 87.0% | 6.61▲ 0% |
| EPS Growth % | -6.71% | -79.9% | 459.26% | -378.15% | 116.51% | -260.58% | 137.72% | 173.81% | 86.96% | 2.03% |
| EPS (Basic) | 4.06 | 0.82 | 4.54 | -12.60 | 2.09 | -3.34 | 1.26 | 3.48 | 6.48 | - |
| Diluted Shares Outstanding | 320M | 315M | 301M | 293M | 294M | 279M | 262M | 247M | 242M | 236M |
| Basic Shares Outstanding | 317M | 313M | 300M | 293M | 292M | 279M | 261M | 245M | 241M | 235M |
| Dividend Payout Ratio | 44.8% | 226.95% | 42.33% | - | 93.78% | - | 159.09% | 58.57% | 31.65% | - |
CAH Balance Sheet
Cardinal Health, Inc. (CAH) balance sheet — assets, liabilities & shareholders' equity
| Line item | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 28.34B | 24.55B | 25.75B | 25.94B | 31.05B | 32.94B | 33.74B | 34.88B | 36.37B | 38.06B |
| Cash & Short-Term Investments | 6.88B | 1.76B | 2.53B | 2.77B | 3.41B | 4.72B | 4.08B | 5.13B | 3.87B | 3.94B |
| Cash Only | 6.88B | 1.76B | 2.53B | 2.77B | 3.41B | 4.72B | 4.08B | 5.13B | 3.87B | 3.94B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 8.05B | 7.8B | 8.45B | 8.26B | 9.1B | 10.56B | 11.11B | 12.08B | 13.24B | 13.65B |
| Days Sales Outstanding | 22.6 | 20.81 | 21.19 | 19.72 | 20.45 | 21.26 | 19.78 | 19.45 | 21.72 | 19.78 |
| Inventory | 11.3B | 12.31B | 12.82B | 13.2B | 14.59B | 15.64B | 16.12B | 14.96B | 16.83B | 18.01B |
| Days Inventory Outstanding | 33.42 | 34.66 | 33.74 | 32.98 | 34.21 | 32.64 | 29.7 | 24.88 | 28.65 | 27.42 |
| Other Current Assets | 0 | 756M | 0 | 0 | 1.1B | 0 | 72M | 2.71B | 2.43B | 2.47B |
| Total Non-Current Assets | 11.77B | 15.4B | 15.22B | 14.83B | 13.4B | 10.94B | 9.61B | 10.24B | 16.75B | 18.63B |
| Property, Plant & Equipment | 1.88B | 2.49B | 2.36B | 2.37B | 2.36B | 2.36B | 2.46B | 2.53B | 2.86B | 2.93B |
| Fixed Asset Turnover | 69.17x | 55.01x | 61.77x | 64.63x | 68.84x | 76.80x | 83.29x | 89.69x | 77.88x | 87.19x |
| Goodwill | 7.22B | 8.32B | 8.38B | 8.36B | 7.99B | 5.86B | 4.61B | 4.72B | 9.69B | 13.7B |
| Intangible Assets | 1.99B | 3.91B | 3.43B | 2.92B | 2.1B | 1.77B | 1.47B | 1.73B | 2.49B | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 68M | 77M | 56M | 43M | 14M | 14M |
| Other Non-Current Assets | 681M | 682M | 1.05B | 1.19B | 883M | 876M | 1.01B | 1.22B | 1.7B | 7.45B |
| Total Assets | 40.11B▲ 0% | 39.95B▼ 0.4% | 40.96B▲ 2.5% | 40.77B▼ 0.5% | 44.45B▲ 9.0% | 43.88B▼ 1.3% | 43.35B▼ 1.2% | 45.12B▲ 4.1% | 53.12B▲ 17.7% | 56.69B▲ 0% |
| Asset Turnover | 3.24x | 3.42x | 3.55x | 3.75x | 3.65x | 4.13x | 4.73x | 5.03x | 4.19x | 4.49x |
| Asset Growth % | 17.55% | -0.4% | 2.53% | -0.48% | 9.04% | -1.29% | -1.21% | 4.09% | 17.73% | 83.24% |
| Total Current Liabilities | 21.22B | 22.89B | 24.11B | 23.61B | 27.62B | 30.55B | 33.74B | 35.64B | 38.9B | 41.99B |
| Accounts Payable | 17.91B | 19.68B | 21.54B | 21.37B | 23.7B | 27.13B | 29.93B | 31.76B | 34.71B | 37.83B |
| Days Payables Outstanding | 52.95 | 55.41 | 56.67 | 53.42 | 55.56 | 56.63 | 55.15 | 52.83 | 59.09 | 56.12 |
| Short-Term Debt | 1.33B | 1B | 452M | 10M | 976M | 682M | 892M | 551M | 714M | 671M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 213M | 0 | 0 | 96M | 0 | 42M | 0 | -164M | 3.48B |
| Current Ratio | 1.34x | 1.07x | 1.07x | 1.10x | 1.12x | 1.08x | 1.00x | 0.98x | 0.94x | 0.94x |
| Quick Ratio | 0.80x | 0.53x | 0.54x | 0.54x | 0.60x | 0.57x | 0.52x | 0.56x | 0.50x | 0.50x |
| Cash Conversion Cycle | 3.07 | 0.06 | -1.74 | -0.71 | -0.9 | -2.73 | -5.67 | -8.51 | -8.73 | -8.91 |
| Total Non-Current Liabilities | 12.06B | 11B | 10.52B | 15.36B | 15.04B | 14.03B | 12.57B | 12.69B | 16.86B | 17.53B |
| Long-Term Debt | 9.07B | 8.01B | 7.58B | 6.76B | 5.32B | 4.69B | 3.85B | 4.58B | 7.82B | 8.24B |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 419M | 437M | 434M | 475M | 811M | 811M |
| Deferred Tax Liabilities | 2.88B | 2.98B | 2.94B | 8.59B | 8.31B | 3.02B | 3.14B | 3.09B | 2.43B | 28.41B |
| Other Non-Current Liabilities | 118M | 12M | 0 | 0 | 981M | 5.89B | 5.14B | 4.54B | 5.8B | 7.09B |
| Total Liabilities | 33.28B | 33.89B | 34.63B | 38.97B | 42.66B | 44.58B | 46.31B | 48.33B | 55.76B | 59.36B |
| Total Debt | 10.39B | 9.01B | 8.03B | 6.78B | 6.71B | 5.8B | 5.18B | 5.61B | 9.35B | 8.92B |
| Net Debt | 3.52B | 7.25B | 5.5B | 4B | 3.31B | 1.09B | 1.1B | 476M | 5.47B | 4.98B |
| Debt / Equity | 1.52x | 1.49x | 1.27x | 3.78x | 3.74x | - | - | - | - | -3.34x |
| Debt / EBITDA | 3.66x | 7.78x | 2.62x | - | 5.35x | 68.29x | 3.58x | 2.87x | 3.05x | 2.82x |
| Net Debt / EBITDA | 1.24x | 6.26x | 1.80x | - | 2.64x | 12.80x | 0.76x | 0.24x | 1.78x | 1.78x |
| Interest Coverage | 10.57x | 0.31x | 6.96x | -14.85x | 2.79x | -4.33x | 8.89x | 24.55x | 10.77x | 6.38x |
| Total Equity | 6.83B▲ 0% | 6.06B▼ 11.3% | 6.33B▲ 4.5% | 1.79B▼ 71.7% | 1.79B▲ 0.1% | -706M▼ 139.4% | -2.96B▼ 318.8% | -3.21B▼ 8.6% | -2.63B▲ 18.0% | -2.67B▲ 0% |
| Equity Growth % | 3.91% | -11.26% | 4.47% | -71.69% | 0.11% | -139.35% | -318.84% | -8.62% | 18% | 1.42% |
| Book Value per Share | 21.34 | 19.23 | 21.03 | 6.12 | 6.10 | -2.53 | -11.29 | -13.00 | -10.88 | -11.32 |
| Total Shareholders' Equity | 6.81B | 6.06B | 6.33B | 1.79B | 1.79B | -709M | -2.96B | -3.21B | -2.78B | -2.83B |
| Common Stock | 2.7B | 2.73B | 2.76B | 2.79B | 2.81B | 2.81B | 2.75B | 2.92B | 2.96B | -7.22B |
| Retained Earnings | 4.97B | 4.64B | 5.43B | 1.17B | 1.21B | -280M | -642M | -286M | 783M | 1.73B |
| Treasury Stock | -731M | -1.22B | -1.79B | -2.07B | -2.19B | -3.13B | -4.91B | -5.68B | -6.37B | 0 |
| Accumulated OCI | -125M | -92M | -79M | -104M | -34M | -114M | -151M | -167M | -155M | -161M |
| Minority Interest | 20M | 0 | 2M | 3M | 3M | 3M | 1M | 1M | 147M | 160M |
CAH Cash Flow Statement
Cardinal Health, Inc. (CAH) cash flow — operating, investing & free cash flow history
| Line item | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.18B | 2.77B | 2.72B | 1.96B | 2.43B | 3.12B | 2.84B | 3.76B | 2.4B | 2.4B |
| Operating CF Margin % | 0.91% | 2.02% | 1.87% | 1.28% | 1.5% | 1.72% | 1.39% | 1.66% | 1.08% | - |
| Operating CF Growth % | -60.15% | 133.78% | -1.66% | -27.99% | 23.93% | 28.53% | -8.9% | 32.28% | -36.28% | 366.59% |
| Net Income | 1.29B | 259M | 1.36B | -3.69B | 612M | -933M | 331M | 853M | 1.57B | 1.56B |
| Depreciation & Amortization | 717M | 1.03B | 1B | 913M | 783M | 723M | 692M | 710M | 790M | 924M |
| Stock-Based Compensation | 96M | 85M | 82M | 90M | 89M | 0 | 96M | 121M | 244M | 462M |
| Deferred Taxes | 291M | -1.01B | -83M | -961M | 496M | 7M | -40M | -104M | 243M | 0 |
| Other Non-Cash Items | 53M | 1.5B | -397M | -450M | 160M | 5.67B | 1.31B | 672M | 74M | 591M |
| Working Capital Changes | -1.27B | 907M | 755M | 6.06B | 289M | -2.35B | 457M | 1.51B | -523M | 1.48B |
| Change in Receivables | -665M | -871M | -751M | 82M | -904M | -1.41B | -950M | -996M | -833M | -681M |
| Change in Inventory | -673M | -1.21B | -551M | -409M | -1.58B | -1.2B | -412M | 1.11B | -1.82B | -2.49B |
| Change in Payables | 564M | 2.57B | 1.86B | -162M | 2.33B | 0 | 2.82B | 1.82B | 2.73B | 4.79B |
| Cash from Investing | -405M | -5.61B | 338M | 493M | -378M | 567M | -454M | -1.85B | -5.61B | -3.95B |
| Capital Expenditures | -387M | -384M | -328M | -375M | -400M | -387M | -481M | -511M | -547M | -617M |
| CapEx % of Revenue | 0.3% | 0.28% | 0.23% | 0.25% | 0.25% | 0.21% | 0.23% | 0.23% | 0.25% | - |
| Acquisitions | -132M | -6.14B | -82M | 0 | -3M | 901M | -10M | -1.19B | -5.25B | -3.36B |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 3M | 862M | 763M | 2M | 0 | 31M | 8M | 18M | -10M | 4M |
| Cash from Financing | 3.75B | -2.28B | -2.29B | -2.2B | -1.32B | -2.46B | -3.05B | -847M | 1.95B | -444M |
| Debt Issued (Net) | 4.86B | -1B | -1.1B | -1.4B | -570M | -885M | -579M | 356M | 3.22B | 1.14B |
| Equity Issued (Net) | -600M | -550M | -600M | -350M | -200M | -1B | -2B | -750M | -765M | -243M |
| Dividends Paid | -577M | -581M | -577M | -569M | -573M | -559M | -525M | -499M | -494M | -491M |
| Share Repurchases | -600M | -550M | -600M | -350M | -200M | -1B | -2B | -750M | -765M | -243M |
| Other Financing | 59M | -144M | -14M | 120M | 26M | -19M | 53M | 46M | -13M | -853M |
| Net Change in Cash | 4.52B▲ 0% | -5.12B▼ 213.1% | 768M▲ 115.0% | 240M▼ 68.8% | 636M▲ 165.0% | 1.31B▲ 106.0% | -669M▼ 151.1% | 1.06B▲ 258.0% | -1.26B▼ 219.1% | 611M▲ 0% |
| Free Cash Flow | 797M▲ 0% | 2.38B▲ 199.1% | 2.39B▲ 0.4% | 1.58B▼ 33.8% | 2.03B▲ 28.0% | 2.73B▲ 34.8% | 2.36B▼ 13.6% | 3.25B▲ 37.6% | 1.85B▼ 43.1% | 4.39B▲ 0% |
| FCF Margin % | 0.61% | 1.74% | 1.65% | 1.04% | 1.25% | 1.51% | 1.15% | 1.43% | 0.83% | 1.75% |
| FCF Growth % | -68.2% | 199.12% | 0.42% | -33.79% | 28.01% | 34.8% | -13.6% | 37.58% | -43.09% | 80.07% |
| FCF per Share | 2.49 | 7.57 | 7.95 | 5.41 | 6.90 | 9.80 | 9.02 | 13.16 | 7.64 | 7.64 |
| FCF Conversion (FCF/Net Income) | 0.92x | 10.81x | 2.00x | -0.53x | 3.98x | -3.33x | 8.62x | 4.42x | 1.54x | 2.82x |
| Interest Paid | 200M | 320M | 285M | 226M | 182M | 0 | 203M | 214M | 315M | 0 |
| Taxes Paid | 686M | 425M | 311M | 368M | 273M | 0 | 156M | 191M | 444M | 0 |
CAH Key Ratios
Cardinal Health, Inc. (CAH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 19.23% | 3.97% | 22% | -90.94% | 34.08% | -172.43% | - | - | - | -58.08% |
| Return on Invested Capital (ROIC) | 15.82% | 0.8% | 12.29% | -34.87% | 6.5% | -16.6% | - | - | 3378.71% | 3378.71% |
| Gross Margin | 5.03% | 5.25% | 4.7% | 4.49% | 4.17% | 3.58% | 3.36% | 3.27% | 3.67% | 3.68% |
| Net Margin | 0.99% | 0.19% | 0.94% | -2.42% | 0.38% | -0.52% | 0.16% | 0.38% | 0.7% | 0.62% |
| Debt / Equity | 1.52x | 1.49x | 1.27x | 3.78x | 3.74x | - | - | - | - | -3.34x |
| Interest Coverage | 10.57x | 0.31x | 6.96x | -14.85x | 2.79x | -4.33x | 8.89x | 24.55x | 10.77x | 6.38x |
| FCF Conversion | 0.92x | 10.81x | 2.00x | -0.53x | 3.98x | -3.33x | 8.62x | 4.42x | 1.54x | 2.82x |
| Revenue Growth | 6.94% | 5.26% | 6.38% | 5.08% | 6.24% | 11.61% | 13.04% | 10.66% | -1.87% | 12.8% |
CAH SEC Filings & Documents
Cardinal Health, Inc. (CAH) SEC filings — annual & quarterly reports (10-K, 10-Q)
CAH Frequently Asked Questions
Cardinal Health, Inc. (CAH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Cardinal Health, Inc. (CAH) reported $250.55B in revenue for fiscal year 2025. This represents a 2610% increase from $9.25B in 1996.
Cardinal Health, Inc. (CAH) saw revenue decline by 1.9% over the past year.
Yes, Cardinal Health, Inc. (CAH) is profitable, generating $1.56B in net income for fiscal year 2025 (0.7% net margin).
Dividend & Returns
Yes, Cardinal Health, Inc. (CAH) pays a dividend with a yield of 1.04%. This makes it attractive for income-focused investors.
Cardinal Health, Inc. (CAH) generated $4.39B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More CAH
Cardinal Health, Inc. (CAH) financial analysis — history, returns, DCA and operating performance tools
Full CAH Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates